Recombinant multi-species PRG4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRG4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a large proteoglycan that is synthesized by chondrocytes located at the surface of articular cartilage and by some synovial lining cells. This protein contains both chondroitin sulfate and keratan sulfate glycosaminoglycans. It functions as a boundary lubricant at the cartilage surface and contributes to the elastic absorption and energy dissipation of synovial fluid. Mutations in this gene result in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
The Alternative Names of target: CACP,DOL54,HAPO,JCAP,Lubricin,MSF,Megakaryocyte-stimulating factor,PRG4,Prg4,Proteoglycan 4,SZP,Superficial zone proteoglycan,lubricin
Go
to PRG4 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T94942-Ag-1/ GM-Tg-hg-T94942-Ag-2 | Human PRG4 protein | Human |
| GM-Tg-rg-T94942-Ag-1/ GM-Tg-rg-T94942-Ag-2 | Rat PRG4 protein | Rat |
| GM-Tg-mg-T94942-Ag-1/ GM-Tg-mg-T94942-Ag-2 | Mouse PRG4 protein | Mouse |
| GM-Tg-cynog-T94942-Ag-1/ GM-Tg-cynog-T94942-Ag-2 | Cynomolgus/Rhesus macaque PRG4 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T94942-Ag-1/ GM-Tg-felg-T94942-Ag-2 | Feline PRG4 protein | Feline |
| GM-Tg-cang-T94942-Ag-1/ GM-Tg-cang-T94942-Ag-2 | Canine PRG4 protein | Canine |
| GM-Tg-bovg-T94942-Ag-1/ GM-Tg-bovg-T94942-Ag-2 | Bovine PRG4 protein | Bovine |
| GM-Tg-equg-T94942-Ag-1/ GM-Tg-equg-T94942-Ag-2 | Equine PRG4 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T94942-Ag-1/ GM-Tg-hg-T94942-Ag-2;
GM-Tg-rg-T94942-Ag-1/ GM-Tg-rg-T94942-Ag-2;
GM-Tg-mg-T94942-Ag-1/ GM-Tg-mg-T94942-Ag-2; GM-Tg-cynog-T94942-Ag-1/ GM-Tg-cynog-T94942-Ag-2; GM-Tg-felg-T94942-Ag-1/ GM-Tg-felg-T94942-Ag-2; GM-Tg-cang-T94942-Ag-1/ GM-Tg-cang-T94942-Ag-2; GM-Tg-bovg-T94942-Ag-1/ GM-Tg-bovg-T94942-Ag-2; GM-Tg-equg-T94942-Ag-1/ GM-Tg-equg-T94942-Ag-2 |
| Products Name | PRG4 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PRG4 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRG4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.